Tod Reel, MD
Family Medicine · Spartanburg, SCNPI 1619952736
Payments from drug & device makers
Across 332 payments — averaging $16.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$984
- Pfizer$423
- AbbVie$410
- Abbott$382
- Esperion Therapeutics, Inc.$304
- Lilly USA, LLC$298
- plus $3K from 35 others
What the payments were for
- Food & beverage$5,33798%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 76 | $984 |
| Pfizer | 26 | $423 |
| AbbVie | 28 | $410 |
| Abbott | 20 | $382 |
| Esperion Therapeutics, Inc. | 16 | $304 |
| Lilly USA, LLC | 19 | $298 |
| Amgen | 18 | $285 |
| Amarin Pharma, Inc. | 19 | $272 |
| Astellas Pharma US Inc | 8 | $238 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $223 |
| Kowa Pharmaceuticals America, Inc. | 15 | $208 |
| Novartis | 8 | $135 |
| GSK | 6 | $104 |
| Merck | 6 | $90 |
| Boehringer Ingelheim | 5 | $81 |
| Neurocrine Biosciences, Inc. | 3 | $69 |
| Exact Sciences | 4 | $69 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $60 |
| Dexcom, Inc. | 2 | $58 |
| Edwards Lifesciences | 2 | $55 |
| Organon | 3 | $55 |
| Medicure Pharma Inc. | 2 | $54 |
| Bayer | 3 | $50 |
| Biohaven Pharmaceuticals, Inc. | 3 | $47 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Dynavax Technologies Corporation | 2 | $43 |
| AstraZeneca | 2 | $43 |
| Pharmacosmos Therapeutics Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Bausch Health US, LLC | 2 | $31 |
| Genentech USA, Inc. | 2 | $29 |
| Medtronic | 1 | $27 |
| Stryker | 1 | $25 |
| Eisai Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Optinose US, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
How this compares
$5,422 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 99 | $92,006 |
| EliquisApixaban | 68 | $68,870 |
| JanuviaSitagliptin Phosphate | 37 | $39,990 |
| FarxigaDapagliflozin Propanediol | 29 | $35,518 |
| RybelsusSemaglutide | 18 | $35,029 |
| JanumetSitagliptin Phos/Metformin Hcl | 24 | $19,739 |
| Repatha SureclickEvolocumab | 24 | $19,626 |
| XareltoRivaroxaban | 12 | $12,872 |
| MyrbetriqMirabegron | 11 | $6,529 |
| Atorvastatin Calcium | 436 | $5,485 |
| Rosuvastatin Calcium | 271 | $5,070 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $4,956 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 36 | $4,479 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 113 | $3,521 |
| Levothyroxine Sodium | 256 | $3,142 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $81 | $92,00699 claims |
| PfizerEliquis | $423 | $68,87068 claims |
| MerckJanuvia, Janumet | $90 | $59,72861 claims |
| AstraZenecaFarxiga | $43 | $35,51829 claims |
| Novo NordiskRybelsus | $984 | $35,02918 claims |
| Johnson & JohnsonXarelto | $14 | $12,87212 claims |
| Astellas Pharma US IncMyrbetriq | $238 | $6,52911 claims |
| AbbVieSynthroid | $410 | $1,73329 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Spartanburg
- Latasha SelibySpartanburg$24K
- George BailesSpartanburg$22K
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.